Collaborating against cancer: MIT’s Koch Institute for Integrative Cancer Research
Cancer encompasses a group of diseases characterized by abnormal cell growth. In the 44 years following the signing of the National Cancer Act of 1971, multiple genetic and environmental factors have been identified as initiators of the disease. Considerable progress has been made in the treatment a...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
De Gruyter
2016-04-01
|
Series: | Nanotechnology Reviews |
Subjects: | |
Online Access: | https://doi.org/10.1515/ntrev-2015-0038 |